Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Weidinger · SciRah

Researcher profile · Semantic Scholar

S. Weidinger

Share profile

S. Weidinger — researcher profile on SciRah

h-index: 85
Works: 584
Citations: 28K

Most-cited papers

GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets
N. Dand, P. Stuart, J. Bowes, D. Ellinghaus +81 more
2025Nature Communications51 citations Open access
Semantic Scholar
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions
M. D. de Bruin-Weller, C. Boesjes, R. Achten, Lisa A. Beck +6 more
2025Allergy. European Journal of Allergy and Clinical Immunology26 citations Open access
Semantic Scholar
Dissecting key contributions of Th2 and Th17 cytokines to atopic dermatitis pathophysiology.
L. Meesters, J. Roubroeks, Aranka Gerritsen, Niels Velthuijs +16 more
2025Journal of Allergy and Clinical Immunology23 citations Open access
Semantic Scholar
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years
C. Bunick, A. Irvine, J. Silverberg, E. Guttman-Yassky +10 more
2025Journal of the European Academy of Dermatology and Venereology20 citations Open access
Semantic Scholar
Stratum corneum and microbial biomarkers precede and characterize childhood atopic dermatitis
M. Fonfara, Jan N. Hartmann, D. Stölzl, N. Sander +10 more
2024Journal of the European Academy of Dermatology and Venereology16 citations Open access
Semantic Scholar
Two-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)
E. Guttman-Yassky, S. Weidinger, E. Simpson, Melinda Gooderham +11 more
2025Dermatologic Therapy15 citations Open access
Semantic Scholar
Early Achievement of High Treatment Targets in Moderate-to-Severe Atopic Dermatitis with Upadacitinib: Real-World Evidence from the Observational UP-TAINED Study
S. Weidinger, T. Schadeck, F. Jacobs, A. Weyergraf +6 more
2025Dermatologic Therapy13 citations Open access
Semantic Scholar
Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE
J. Silverberg, E. Simpson, Andrew E. Pink, S. Weidinger +4 more
2025Dermatologic Therapy11 citations
Semantic Scholar
Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage).
R. Warren, M. D. de Bruin-Weller, A. Tsianakas, Abdallah Khemis +9 more
2025British Journal of Dermatology9 citations Open access
Semantic Scholar
Biomarkers for therapeutic response and adverse outcomes in atopic dermatitis: A systematic review
E. Hilger, Kaitlyn R Chan, A. Yip, Xing-Yue Wang +7 more
2026Journal of the European Academy of Dermatology and Venereology7 citations Open access
Semantic Scholar
Improvement and maintenance of clinical outcome assessments in atopic dermatitis with amlitelimab
A. Blauvelt, R. Chovatiya, J. Merola, S. Weidinger +5 more
2025Journal of the European Academy of Dermatology and Venereology6 citations Open access
Semantic Scholar
A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study
A. Reich, A. Blauvelt, S. Weidinger, V. Shi +6 more
2025Dermatologic Therapy6 citations Open access
Semantic Scholar
Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce
A. Musters, L. Gerbens, L. F. Van der Gang, M. Middelkamp-Hup +25 more
2025Journal of the European Academy of Dermatology and Venereology5 citations Open access
Semantic Scholar
Childhood Asthma and Allergy Are Related to Accelerated Epigenetic Aging
M. Leskien, E. Thiering, Zhebin Yu, Anke Hüls +8 more
2025Allergy. European Journal of Allergy and Clinical Immunology5 citations Open access
Semantic Scholar
Inflammatory Skin Diseases: The Importance of Immunological Signatures.
N. Garzorz-Stark, S. Weidinger, M. Sticherling, Kamran Ghoreschi +2 more
2025Deutsches Ärzteblatt International4 citations
Semantic Scholar
Long-Term Efficacy and Safety of Lebrikizumab Is Maintained in Patients With Moderate-to-Severe Atopic Dermatitis: Results Up to 3 Years From ADjoin
E. Guttman-Yassky, Alan D. Irvine, Eric Simpson, Melinda J. Gooderham +11 more
2025SKIN The Journal of Cutaneous Medicine3 citations Open access
Semantic Scholar
Defining “Flares” in Atopic Dermatitis: A Narrative Review
J. Merola, S. Weidinger, Sally Y. Tan, Kassim Rahawi +1 more
2025American Journal of Clinical Dermatology3 citations Open access
Semantic Scholar
Psychoeducational schema therapy for psoriasis and atopic dermatitis: a randomized controlled pilot crossover trial
R. von Spreckelsen, H. Emmert, Jan N. Hartmann, M. Hübenthal +4 more
2026Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2 citations Open access
Semantic Scholar
Integrated Methylome–Transcriptome Analysis Reveals Epigenomic Remodeling and Rho GTPase–Linked Immune–Epithelial Crosstalk in Atopic Dermatitis
T. Skoog, Ying Yang, P. Olah, S. Katayama +10 more
2026Allergy. European Journal of Allergy and Clinical Immunology2 citations Open access
Semantic Scholar
Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis.
E. Guttman-Yassky, Thomas Bieber, K. Kabashima, J. Gutermuth +6 more
2026Journal of dermatological treatment (Print)2 citations Open access
Semantic Scholar
Multi‐omics profiling of chronic immune‐mediated skin diseases: SKINERGY protocol and strategic evaluation
N. Koster, J. M. Van den Reek, E. D. De Jong, S. van Beugen +40 more
2026Journal of the European Academy of Dermatology and Venereology2 citations Open access
Semantic Scholar
Antigen-restricted Candida albicans Th17 cells link oral-gut immunity and adopt pathogenic features during intestinal inflammation.
G. Martini, Philipp Hofmann, Ann-Kristin Kamps, A. Weichberger +26 more
2026Immunity2 citations Open access
Semantic Scholar
Collagen XXIII (COL23A1): A novel risk factor for eczema herpeticum.
S. Chopra, J. Zeitvogel, S. Traidl, I. Klug +9 more
2025Journal of Allergy and Clinical Immunology2 citations Open access
Semantic Scholar
In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody
J. G. Krueger, Brian S Kim, S. Weidinger, Yoko Kataoka +4 more
2025Acta Dermato-Venereologica2 citations Open access
Semantic Scholar
Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry
B. Kind, L. Heinrich, T. Werfel, J. Schmitt +1 more
2025Acta Dermato-Venereologica2 citations Open access
Semantic Scholar
The importance of registries in clinical practice: Insights from the national atopic dermatitis registry TREATgermany
T. Honstein, B. Kind, D. Stölzl, I. Harder +9 more
2025Allergologie select2 citations Open access
Semantic Scholar
Effects of a Gel Containing the Defined Microalgae Extract Spiralin® on the Skin Microbiome and Clinical Activity in Atopic Dermatitis: A Double-Blind, Intraindividual Vehicle-Controlled Proof-Of-Concept Study
K. Reich, Natalie Trettel, J. Reich, C. Sorbe +5 more
2025Skin Pharmacology and Physiology2 citations Open access
Semantic Scholar
Flexible Dosing of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Initial Results From the Real-World–Simulating Expanded Access Protocol Study, JADE REAL
R. Chovatiya, M. Zirwas, Eric Simpson, Melinda J. Gooderham +5 more
2025SKIN The Journal of Cutaneous Medicine2 citations Open access
Semantic Scholar
494 - Efficacy and safety of lebrikizumab is maintained to two years in patients with moderate-to-severe atopic dermatitis
E. Guttman-Yassky, S. Weidinger, E. Simpson, M. Gooderham +11 more
2024British Journal of Dermatology2 citations
Semantic Scholar
Clinical and molecular improvements in pediatric patients with atopic dermatitis treated with dupilumab: an analysis from the TREATKids registry.
M. Fonfara, D. Stölzl, Jan N. Hartmann, I. Harder +19 more
2026Journal of Investigative Dermatology1 citations
Semantic Scholar
Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)
E. Guttman-Yassky, Alan D. Irvine, Melinda Gooderham, S. Weidinger +10 more
2026Dermatologic Therapy1 citations Open access
Semantic Scholar
Influence of mode of delivery on neonatal QTc
Christina Eder, Stephan Gerling, Susanne Brandstetter, M. Dechant +25 more
2026Journal of Perinatology1 citations Open access
Semantic Scholar
Sustained On- and Off-Treatment Disease Control in Patients With Moderate-to-Severe Atopic Dermatitis Following 12-Week, Open-Label, Once-Daily Abrocitinib 200 mg: A Post Hoc Analysis of the Phase 3 JADE REGIMEN Study
E. Guttman-Yassky, T. Bieber, J. Gutermuth, K. Kabashima +6 more
2026SKIN The Journal of Cutaneous Medicine1 citations Open access
Semantic Scholar
The inflammatory skin disease map: an interactive computational resource focused on psoriasis and atopic dermatitis molecular mechanisms.
M. Acencio, O. Lopata, A. Hemedan, N. Dand +13 more
2025British Journal of Dermatology1 citations Open access
Semantic Scholar
Tailoring Abrocitinib Treatment for Moderate-to-Severe Atopic Dermatitis to Patient Disease Course: A Narrative Review
J. Silverberg, E. Simpson, Melinda Gooderham, S. Weidinger +2 more
2025Dermatologic Therapy1 citations Open access
Semantic Scholar
Th2‐Polarised CD4+ T Cells Enhance Staphylococcus aureus Growth in a 3D Skin Model
I. Suhrkamp, M. Fonfara, Magdalena Magdalena, Jan N. Hartmann +4 more
2025Clinical and Experimental Allergy1 citations Open access
Semantic Scholar
A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
E. Gribaleva, N. S. Krogh, D. Prieto-Merino, Bola Coker +26 more
2025Skin Health and Disease1 citations Open access
Semantic Scholar
Implementing Federated Analysis using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries Collaboration.
N. S. Krogh, D. Prieto-Merino, Bola Coker, T. Birkner +27 more
2025Journal of Investigative Dermatology1 citations Open access
Semantic Scholar
TREATkids: Das deutsche AD-Register im Kindes- und Jugendalter stellt sich vor
S. Abraham, H. Ott, K. Nemat, B. Kind +10 more
2025Allergologie1 citations
Semantic Scholar
Endothelin-2 from Keratinocytes and its Association with Itch in Skin Diseases
Yumeng Dong, M. Sarkar, Yuntian Wu, Xian-Ying Xing +8 more
2025Journal of Investigative Dermatology1 citations Open access
Semantic Scholar
Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis
Gilles Tiraboschi, K. Papp, Thomas Bieber, S. Weidinger +7 more
2025CPT: Pharmacometrics & Systems Pharmacology1 citations Open access
Semantic Scholar
Durability of Response After Pausing Abrocitinib Treatment in Patients With Moderate-to-Severe Atopic Dermatitis
S. Weidinger, Y. Kataoka, Brian S. Kim, I. Lazariciu +3 more
2025SKIN The Journal of Cutaneous Medicine1 citations Open access
Semantic Scholar
62188 Amlitelimab Reduces Th2-, Th1-, and Th17/22-Related Cytokines and Chemokines in Adults With Moderate-to-Severe Atopic Dermatitis): Results From an Exploratory Analysis of the Phase 2b STREAM-AD Study
Bob Geng, S. Weidinger, Saeko Nakajima, D. Leung +5 more
2025Journal of American Academy of Dermatology1 citations
Semantic Scholar
619 - Lebrikizumab improves signs and symptoms of moderate-to-severe atopic dermatitis in patients not adequately controlled or non-eligible for cyclosporine: a placebo-controlled, randomized phase 3 clinical study (ADvantage)
Richard B. Warren, M. D. de Bruin-Weller, A. Tsianakas, Abdallah Khemis +8 more
2024British Journal of Dermatology1 citations
Semantic Scholar
520 - Evaluating the expression of OX40 and OX40 ligand in lesional skin versus non-lesional skin in volunteers with atopic dermatitis and in healthy control skin
S. Weidinger, T. Watkins, Adrian N. Carr, Davide Lucchesi +2 more
2024British Journal of Dermatology1 citations
Semantic Scholar
P149 Efficacy of lebrikizumab at 16 weeks: pooled analyses from the ADvocate1 and ADvocate2 phase III trials in adolescent and older adult patients with moderate-to-severe atopic dermatitis
Carsten Flohr, Adelaide A. Hebert, M. Zirwas, M. Napolitano +13 more
2026British Journal of Dermatology0 citations
Semantic Scholar
Keratinocyte Priming by Staphylococcus aureus Reduces HSV‐1 Susceptibility
P. Baumann, R. Pospich, Katinka Döhner, I. Klug +15 more
2026Allergy. European Journal of Allergy and Clinical Immunology0 citations Open access
Semantic Scholar
73841 Efficacy and Safety of Lebrikizumab is Maintained up to 4 Years in Patients With Moderate-to-Severe Atopic Dermatitis: first year of ADlong Long-Term Extension Trial
S. Weidinger, Alan D. Irvine, D. Thaçi, J. Szepietowski +7 more
2026Journal of American Academy of Dermatology0 citations
Semantic Scholar
77113 Efficacy of abrocitinib therapy in daily practice: clinician- and patient-reported outcomes in a heterogeneous TREATgermany registry cohort using AHEAD criteria
S. Abraham, B. Kind, Frederic Gehrke, S. Beissert +3 more
2026Journal of American Academy of Dermatology0 citations
Semantic Scholar
Multi-cytokine based TWAS for seven inflammatory skin disorders identify candidate causal genes in keratinocytes.
Haihan Zhang, M. Patrick, M. Sarkar, Rachael Bogle +20 more
2026Journal of Allergy and Clinical Immunology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Werfel×9
Invite
T. Werfel — researcher profile on SciRah
J. Silverberg×7
Invite
J. Silverberg — researcher profile on SciRah
Jan N. Hartmann×6
Invite
Jan N. Hartmann — researcher profile on SciRah
D. Stölzl×6
Invite
D. Stölzl — researcher profile on SciRah

×6

Invite

I. Harder — researcher profile on SciRah

Alan D. Irvine×6

Invite

Alan D. Irvine — researcher profile on SciRah

M. D. de Bruin-Weller×5

Invite

M. D. de Bruin-Weller — researcher profile on SciRah

E. Guttman-Yassky×5

Invite

E. Guttman-Yassky — researcher profile on SciRah

Jochen Schmitt×5

Invite

Jochen Schmitt — researcher profile on SciRah

H. Elmaraghy×5

Invite

H. Elmaraghy — researcher profile on SciRah

Invite

E. Pierce — researcher profile on SciRah

Invite

H. Agell — researcher profile on SciRah